Esther Welkowsky
Directeur Technique/Scientifique/R&D chez ELICIO THERAPEUTICS, INC.
Profil
Esther Welkowsky is currently the Vice President-Clinical Development at Elicio Therapeutics, Inc. (United States) and the Senior Vice President-Clinical Development at Elicio Therapeutics, Inc. She previously worked as the Executive Director-Clinical Operations at Allogene Therapeutics, Inc. from 2018 to 2020.
Prior to that, she was the Head-Clinical Operations at Atara Biotherapeutics, Inc. Ms. Welkowsky completed her undergraduate degree at the University of California, Santa Barbara.
Postes actifs de Esther Welkowsky
| Sociétés | Poste | Début |
|---|---|---|
| ELICIO THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/04/2020 |
Anciens postes connus de Esther Welkowsky
| Sociétés | Poste | Fin |
|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/02/2020 |
| ATARA BIOTHERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Esther Welkowsky
| University of California, Santa Barbara | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ALLOGENE THERAPEUTICS, INC. | Health Technology |
| ATARA BIOTHERAPEUTICS, INC. | Health Technology |
| ELICIO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
